Meropenem Aptapharma

Meropenem, the active ingredient in Meropenem Aptapharma, is a carbapenem antibiotic presented as an injectable solution for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, nosocomial pneumonia, and septicemia in hospitalized patients.

GNH USA supplies Meropenem Aptapharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem is a carbapenem antibiotic used to treat serious bacterial infections.

Complicated intra‑abdominal infections: provides clinical cure and microbiological eradication. Complicated urinary tract infections: eliminates pathogenic Gram‑negative and Gram‑positive organisms. Nosocomial pneumonia: achieves rapid bacterial clearance in ventilated patients. Septicemia: controls bloodstream infections caused by susceptible bacteria.

Adverse reactions may occur with meropenem therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal discomfort. - Diarrhea: may be watery and self‑limiting. - Headache: transient and usually resolves without intervention. - Rash: mild erythematous skin eruption. - Elevated liver enzymes: transient increase in ALT/AST. - Injection site pain: local discomfort during IV administration.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disorders. - Severe allergic reactions: anaphylaxis, angioedema, or Stevens‑Johnson syndrome. - Clostridioides difficile‑associated colitis: severe diarrhea and colitis. - Neutropenia or thrombocytopenia: marked reduction in blood cell counts. - Renal toxicity: acute kidney injury in predisposed individuals. - Hepatotoxicity: rare cases of liver failure.

Meropenem should be used with careful clinical monitoring. - Renal function: adjust dose in patients with impaired clearance. - Hypersensitivity: avoid in individuals with known carbapenem allergy. - Seizure risk: monitor neurologic status, especially in CNS disease. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Concomitant antibiotics: assess for additive toxicity. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with several medicines.

Major Interactions (Avoid): - Valproic acid: reduces serum levels, increasing seizure risk. - Other carbapenems: additive neurotoxicity, especially seizures. - Nephrotoxic agents (e.g., amphotericin B): heightened renal injury.

Moderate Interactions (Monitor Closely): - Loop diuretics: monitor electrolytes and renal function. - Aminoglycosides: watch for combined nephrotoxicity. - Warfarin: periodic INR checks recommended.